VYNE Therapeutics (VYNE)

• Market cap: $21.8M
• 1 day: -0.52%
• 5 days: 0.86%
• 1 month: -4.59%
• 3 months: 4.99%
• 6 months: 10.26%
• Year to date: 11.8%
• 1 year: -59.98%
• 5 years: -99.01%
• 10 years: -99.97%
• Sector: Healthcare
• Industry: Biotechnology

About: VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company is also in the pre-clinical stages of research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in human. Its products include AMZEEQ, ZILXI, and FCD105.

Employees: 10